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Abstract
The hepatic nuclear factor HNF4a is a versatile transcription factor and controls expression of many genes in development,
metabolism and disease. To delineate its regulatory gene network in colon cancer and to define novel gene targets a
comprehensive genome-wide scan was carried out at a resolution of 35 bp with chromatin IP DNA obtained from the
human colon carcinoma cell line Caco-2 that is a particularly rich source of HNF4a. More than 90% of HNF4a binding sites
were mapped as promoter distal sequences while enhancer elements could be defined to foster chromatin loops for
interaction with other promoter-bound transcription factors. Sequence motif analysis by various genetic algorithms
evidenced a unique enhanceosome that consisted of the nuclear proteins ERa, AP1, GATA and HNF1a as cooperating
transcription factors. Overall .17,500 DNA binding sites were identified with a gene/binding site ratio that differed .6-fold
between chromosomes and clustered in distinct chromosomal regions amongst .6600 genes targeted by HNF4a. Evidence
is presented for nuclear receptor cross-talk of HNF4a and estrogen receptor a that is recapitulated at the sequence level.
Remarkably, the Y-chromosome is devoid of HNF4a binding sites. The functional importance of enrichment sites was
confirmed in genome-wide gene expression studies at varying HNF4a protein levels. Taken collectively, a genome-wide
scan of HNF4a binding sites is reported to better understand basic mechanisms of transcriptional control of HNF4a targeted
genes. Novel promoter distal binding sites are identified which form an enhanceosome thereby facilitating RNA processing
events.
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Introduction
Hepatic nuclear factor HNF4a is a member of the nuclear
receptor superfamily and an extremely versatile transcription
factor [1]. This zinc finger protein is expressed in liver, intestine,
pancreas and other tissues, and binds to cognate DNA sequences
as a homodimer [2]. In the past, some dozen promoter binding
sites were reported. The use of chromatin immunoprecipitation
and microarray hybridization ChIP-chip methodologies demon-
strated that these are only the smallest fraction of the actual
HNF4a binding sites. By use of tiling array encompassing the
ENCODE regions that represent 1% of the genome in the human
hepatoma cell line HepG2 [3] a total of 194 HNF4a binding sites
could be mapped. In another study HNF4a binding sites in
hepatocytes and pancreatic islets were mapped, but the approach
focused on promoter regions only [4]. As of today, a genome-wide
footprint of HNF4a has not been reported. Notably, HNF4a is a
master regulatory protein and dysfunction of HNF4a has been
associated with metabolic and cancerous diseases. We were par-
ticularly interested in exploring an HNF4a genomic footprint in
the human colon adenocarcinmoa Caco-2 cell line that has been
widely used to explore HNF4a activity [5] thereby identifying a
network of regulated genes. Specifically, the cell line differentiates
into enterocytes upon confluence [6] and expresses HNF4a pro-
tein comparable to liver [7]. Here we report the first genome-wide
scan that enabled an identification of .17,500 binding sites
targeted by HNF4a and describe their chromosomal distribution.
Additionally, we studied the consequences of HNF4a protein
induction on transcriptional activity of de novo identified genes and
demonstrate good agreement between novel gene targets and their
expression in Caco-2 cells. Finally, we analyzed HNF4a binding
sites for enriched binding motifs and identified cooperating
transcription factors that appeared to act in concert with HNF4a
in an enhanceosome of transcriptional regulation.
Results
Chromatin IP experiments were performed with Caco-2 cell
cultures and an antibody highly specific for HNF4a. Notably, total
input as well as IP-DNA from three independent biological
replicates was obtained and subjected to an optimized protocol for
unbiased amplification according to the manufactures recommen-
dation (see also Material and Method section). The amplified
DNA from independent experiments was hybridized to Affymetrix
Human tiling 2.0R arrays with a genome-wide resolution of 35 bp.
Then, raw data were examined for enriched regions by use of
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28three independent algorithms (TAS [8], MAT [9] and Tilemap
[10]). Initial cutoff criteria were set on the weakly enriched positive
control (OTC) and further improved based on the frequency of
HNF4a -motifs within the enriched regions, as determined by the
MATCH algorithm [11]. To gain confidence in the data, results
from the three algorithms were intersected. The overlap of enrich-
ment sites (ES) identified by the three approaches was very high
(Fig. 1), even though small differences were observed possibly due
to the different repeat libraries used. Overall this approach led
to an identification of 17,561 ES (Supplementary Table S1).
Moreover, a low stringency data set was generated by merging ES
data detected with the MAT and Tilemap algorithms. This
resulted in a total of 25,419 ES (Supplementary Table S2).
Additionally, 15 ES of known HNF4a gene targets were chosen
and their enrichment in the primary IP-DNA was determined by
realtime quantitative PCR. For all selected sites enrichment could
be confirmed. Thus the robustness and quality of the data was
validated (Fig. 2). Among the identified ES there were HNF4a
binding sites already described in the literature or reported
elsewhere such as AAT (R00114), GCC (R08885), PCK (R12074),
APOB (R01612), CYP2C9 (R15905), AKR1C4 (R13037), ACADM
(R15923) or CYP27A1 (R15917). In the case of SHBG (R15941),
ES were determined within a few hundred base pairs relative
to the reported binding sites. Other binding sites described in
literature, like ALDH2 (R15845), could not be confirmed. How-
ever, quantification by real time PCR showed that the ALDH2 site
was not enriched in the primary IP-DNA. As the HNF4a protein
functions in a tissue specific manner, it is not unexpected that some
ES are not bound in Caco-2 cells; their accessibility rather depends
on chromatin organization, which in turn depends on the cell type.
This is supported by independent investigations, where significant
differences in DNA binding sites in different cell types had been
observed [12].
The HNF4a motif is highly enriched within the ChIP regions
ChIP-enriched regions were examined for HNF4a binding
motifs with the MATCH algorithm [11]. Using stringent criteria
to minimize false positives, .14-fold enrichment was observed for
HNF4a targeted sequences when compared to genomic back-
ground (Supplementary Table S3).
The regions of 500 bp surrounding the 17,561 identified
binding sites were analyzed for HNF4a motifs with settings to
minimize false negatives by use of the MATCH algorithm [11].
Essentially, regions were segmented into bins of 25 bp, and the
number of occurrences of the different motifs within each bin was
counted. This resulted in a total of 23,145 motifs and equates to
1.32 motifs / ChIP region. For 98.1% of the ChIP regions at least
one motif was detected. This suggests that most of the ChIP
regions were enriched due to direct binding of HNF4a.B yt h e
same approach the binding sites reported for the ENCODE
regions [3] were examined and 1.13 motifs / Chip region were
estimated which is less than observed in the present study to
possibly suggest high resolution tiling arrays to better identify ES.
Subsequently, the distribution of the HNF4a motifs around the
center of the ChIP enriched regions was analyzed (Fig. 3a). The
majority of motifs is located in a region of only ,500 base pairs.
When the enriched regions at the peak positions detected with the
MAT algorithm were aligned against the center position, the
number of HNF4a motifs increased, therefore indicating that the
peak position better estimates actual binding site. Additionally, the
Gibbs motif sampler was applied to identify ES regions to enable
easy de novo definition of the HNF4a motif (Fig. 3b).
To underline the biological importance of the identified binding
sites their average conservation was studied as well. The nucleo-
tides in the center, where a binding site could be expected, show a
two times higher conservation than those at the ends of the plot
(genomic background) (Fig. 3c). Again, when the ChIP enriched
regions were aligned by the peak position, the conservation peak
was even better defined.
HNF4a binds predominantly to enhancer elements
The distance from HNF4a binding site to the closest tran-
scription start site (TSS) of a RefSeq gene was determined. Here, a
nearly 5-fold overrepresentation of binding sites in the promoter
region of 21000 to 0 relative to the TSS was observed (Fig. 4a,
b). However, only 5,8% of all binding sites mapped to promoter-
proximal regions and 3,6% of all RefSeq promoters are bound by
HNF4a. A similar and significant lack of preference for binding to
59 promoter-proximal regions had been reported for the tran-
scription factors Sp1, P53, cMyc and ERa [13,8]. While some
transcription factors like E2F1 show a clear preference for 59
promoter-proximal regions [14], accumulating evidence is highly
suggestive for promoter-proximal regions to constitute only a small
fraction of mammalian gene regulatory sequences. Indeed, some
of the nuclear receptors display higher activity at enhancer rather
than promoter binding sites [13,15]. Consequently, studies with
promoter arrays are of limited value.
An analysis of the distribution of ES at 600 bp surrounding the
TSS provided evidence for preferential binding in the upstream
region (Fig. 4c and d). However, at a distance greater than
800 bp of the TSS, more binding sites are located downstream.
Notably, many transcription factors binding sites are located in the
first intron; the second peak shown in Fig. 4c is due to binding of
intronic regions. The frequency of HNF4a binding sites in RefSeq
annotated genes was further analyzed. This evidenced an
overrepresentation of ES in the first introns, but less so in the
second or third (Fig. 4d).
Importantly, a recent HNF4a ChIP-chip study suggested
promoter-proximal ES are due to indirect interactions of HNF4a
with other transcription factors [3]. Consequently, a model was
developed whereby HNF4a binds to distant enhancer elements and
creates chromatin loops by interacting with other promoter-bound
Figure 1. Venn diagram of overlap between HNF 4a binding
sites identified by different algorithms. Raw data was analyzed
with three different programs (Tilemap, MAT and TAS) to identify
HNF4a binding sites. Although different parameter settings (e.g. band
width of 200, 300 and 400 nucleotides) and different algorithms were
used, the overlap was surprisingly high. The Venn diagram was
calculated using the intersect function of Galaxy [47].
doi:10.1371/journal.pone.0021667.g001
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than 1% of genomic sequences. Based on the genome wide scan
reported herein HNF4a binding motifs in promoter-distal regions
are overrepresented as compared to promoter-proximal regions
(Fig. 5a), nonetheless regions with low enrichment display a higher
percentage of promoter-proximal binding sites than regions with
high enrichment (Fig. 5b). Possibly, HNF4a contacts promoter-
proximal regions by physical interaction with other transcription
factors and therefore displays promoter as well as an enhancer
binding activity.
The distribution of identified ES across the chromosomes varied
.6 fold. Strikingly, the Y chromosome is devoid of HNF4a ES
(Supplementary Table S6) and the chromosomal distribution
of ES is not randomly distributed; rather clusters are formed
(Fig. 6a; Fig. 7). These clusters are not related to differences in
the gene density within these regions, as shown for chromosome
10. The region with the highest density of binding sites on
chromosome 10 contains two clusters of binding sites with the
overlapping loci ACSL5 and VTI1A1 (Fig. 6b). By scanning the
genomic sequence for windows of 100,000 bp that contain $10
HNF4a binding sites, fifteen clusters could be defined (Supple-
mentary Table S7). Indeed, most enhancers appear to be
promiscuous and thus regulate multiple genes [16]. While
enhancer activity may take place over hundreds of kilobases [17]
and even cases of inter-chromosomal regulation by enhancers
have been reported [18], most are within 100,000 bp of their
respective TSS. To better define a possible enhanceosome for
target genes sequences closest to RefSeq genes with a TSS sepa-
rated by less than 100,000 nucleotides were selected (Supple-
mentary Table S8).
Figure 2. Validation of HNF4a binding sites. Enrichment of novel HNF4a binding sites detected by ChIP-chip was confirmed by real time PCR.
ChIP-DNA from three independent experiments was used. Normalization was performed using a b-actin negative control, and the values are shown
as fold enrichment versus total input. HNF1a upstream is a second negative control, located upstream of the known HNF4a binding site in the HNF1a
promoter and is used to confirm the ß-actin negative control.
doi:10.1371/journal.pone.0021667.g002
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To search for transcription factor cross-talk the ChIP regions
for overrepresented motifs were considered. Among the motifs
with the highest enrichment are matrices similar to the HNF4a
binding motif, e.g. those for COUP-TF, PPAR or LEF1 (Fig. 8,
Supplementary Tables S3, S4, S5). These transcription
factors are known to compete with HNF4a for common binding
sites [19–21]. However, many motifs dissimilar to HNF4a, e.g. the
binding motifs for HNF1a, AP1 or GATA transcription factors,
were also significantly enriched. If these factors act in common
with HNF4a, it could be expected that the frequency of their
motifs increases with decreasing distance to the HNF4a binding
sites. Therefore, the frequency of such motifs relative to the HNF4a
binding sites was analyzed (Fig. 9a and 9b). The enrichment of
these motifs is restricted to a region of a few hundred base pairs
aroundthepeakposition,thereforesupportingtheideathat theyare
part of an enhanceosome defined by HNF4a. Besides an increase in
the frequency of binding motifs for AP1, GATA, ERa and HNF1a
an inverse relationship between HNF4a and CART motifs was
observed,butthere was no relationship with SREBP1(Fig. 9a). It is
tempting to speculate that this is of regulatory importance for
HNF4a. Other analyzed motifs showed only a slight correlation
between the number of motifs and the distance to the peak position,
although they were clearly enriched in ChIP regions (e.g. USF,
CREB, HNF6).
The high sequence similarity of binding sites for HNF4a and
estrogen receptor (ERa) is of considerable importance (Fig. 9c).
To further analyze the probability of co-occupancy of enriched
motifs the HNF4a binding sites were determined exactly by motif
analysis. The genomic position of the highest scoring HNF4a
motif within the ChIP regions was retrieved and extended to 500
nucleotides to the left and right flanking sequences. Within these
sequences, other enriched motifs were detected and the distance to
the HNF4a motif was calculated (Fig. 9b). As expected, most
ERa motifs co-locate at HNF4a ES causing a high peak at the
center. In contrast, HNF1a, AP1 and GATA motifs display
enrichment at a distance of 20 to 60 nucleotides to the HNF4a
motif.There isalsoanenrichmentoflessconservedHNF4a binding
sites in close proximity to the highest scoring HNF4a motif. This
overrepresentation of less conserved HNF4a motifs may play a role
Figure 3. Enriched regions contain HNF4a binding motifs that are highly conserved. a) HNF4a motifs in the area of 1,000 bp surrounding
enrichment site (ES) peak or center positions as detected with MATCH, using cutoffs to minimize false positives. The distance of the center of
detected motifs to the peak or center position of the ES was calculated. A histogram was created using bins of 50 nucleotides around the center or
peak positions. The blue line shows the deviation of HNF4a motifs relative to the ES center, the red line shows the deviation relative to the peak
position. b) HNF4a ChIP-chip ES to allow easy de novo prediction of the HNF4a binding motif. After analysis of the sequence of regions enriched by
HNF4a ChIP-chip with Gibbs motif sampler, the HNF4a-motif was actually detected two times, with the second motif presenting only half a site. c)
Conservation of all HNF4a binding sites (blue line). ES centers (blue) or Peak positions (red) were extended to 1,000 bp in both directions, and for
each nucleotide the average conservation score, based on the high-quality phast-Cons information from the UCSC GoldenPath Genome Resource,
was calculated. The average conservation scores were plotted against the nucleotides position. Analyses were performed with CEAS [43].
doi:10.1371/journal.pone.0021667.g003
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sequence context surrounding the binding site.
As the ERa motif overlaps partially with the HNF4a motif, it is
tempting to speculate that such enrichment within the ChIP
regions is due to a functional connection between the two factors.
Recently, a genome-wide map of ERa binding sites was reported
[13]. Therefore the data for ERa and HNF4a sites were analyzed
and found to considerably overlap (Fig. 9d). Using either the low
or high stringency set of HNF4a or ERa binding sites up to about
15% of the ERa binding sites were also targeted by HNF4a, thus
supporting the idea of cooperation between HNF4a and the ERa
nuclear receptor. Importantly, several independent investigations
report synergism in the transcription factor activity of HNF4a and
ERa in the gene regulation of, for instance, apolipoprotein A1,
apoVLDII and the small heterodimer partner.
A genome-wide scan reveals HNF4a’s master function
Data from the present study was compared with published data
in order to identify regions which overlap amongst these studies
(Fig. 10). Of the 194 ES reported within the ENCODE regions
[3], 76 overlapped with findings of the present study. Unfortu-
nately, the ENCODE regions comprise 1% of the entire genome
only. Furthermore, in a promoter-focused study [4] 1,553 bound
sequences were reported for hepatocytes. In the present study and
by selecting comparable sequence regions a total of 575 binding
sites could be investigated. Of these, 200 binding sites were in
Figure 4. Distribution of ES relative to RefSeq loci. a) Location of HNF4a binding sites relative to the closest TSS of RefSeq genes as compared
to random distribution. The regions of 100,000 nucleotides surrounding each TSS were divided into bins of 5,000 nucleotides, and the number of
binding sites in each bin was counted. b) Genomic distribution of HNF4a binding sites. The number of binding sites located in the specified regions
of RefSeq annotated genes was calculated by the software tool CisGenome. TSSup1k: 1,000 bp upstream of a transcription start site (TSS);
TESdown1k: 1,000 bp downstream of a transcription end site. c) Distribution of HNF4a binding sites located proximal to TSS of RefSeq genes,
compared to random distribution. The regions of 5,000 nucleotides surrounding each TSS were divided into bins of 200 nucleotides, and the number
of binding sites in each bin was counted. d) Overrepresentation of HNF4a binding sites in upstream and downstream TSS proximal regions and in
first, second an third introns of RefSeq annotated genes, relative to a random control regions. The positions of TSS, first, second and third introns of
RefSeq annotated genes were retrieved from UCSC, and the number of HNF4a binding sites located in the specified regions was calculated.
TSSup600: 600 bp upstream of a transcription start site; TSSdown600: 600 bp downstream of a transcription start site; TSSup10k: 10,000 bp upstream
of a TSS; TSSdown10k: 10,000 bp downstream of a TSS.
doi:10.1371/journal.pone.0021667.g004
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binding sites. Furthermore, the same investigator reported ES for
pancreatic islets but only 9% could be confirmed in the present
study with IP DNA from the Caco-2 cell line. Such differences
may arise from the different experimental protocols and dif-
ferences in cell types.
Biological ontologies of de novo identified HNF4a gene
targets
Based on Gene Ontology the de novo identified genes were
grouped (Supplementary Table S9). Many of the targeted
genes are involved in different metabolic processes, e.g. lipid,
organic acid or carbohydrate metabolism. Categories related to
transport, i.e. lipid transport, were significantly overrepresented as
was fatty acid and cholesterol metabolism [1,22]. Additionally,
many genes for development and differentiation were identified
therefore reassuring HNF4a’s role in development [23] and
epithelial differentiation [22,24–26]. This protein also controls the
insulin secretory pathway [27] and is linked to rare monogenic
disorder, i.e. maturity-onset diabetes of the young (MODY) [28].
Thus, genes targeted by HNF4a in the insulin signaling pathway
as well as such related to cell death and tumour suppressor activity
were identified [29].
Defining functional binding sites - Correlation between
genome-wide HNF4a ChIP-chip and gene expression
data
A common approach to identify genes targeted by a tran-
scription factor is to determine mRNA abundance caused by its
increased or diminished transcriptional activity as investigated in
human embryonic kidney (HEK293 [30]) and hepatoma cells
(HUH7 [31], HepG2 [32]). Surprisingly, HNF4a transfection
experiments influenced transcription of a small number of genes
only. While it is known that transcriptional regulation is not
mediated at the level of DNA binding alone [33] in such
experiments most transcription factors bind under ‘non-activating’
conditions. To confirm functional binding sites of de novo identified
HNF4a gene targets, Caco-2 cell cultures were treated with an
inducer of HNF4a protein [34]. After treatment of Caco-2 cells
with Aroclor 1254, binding of the HNF4a protein to the HNF1a
promoter was increased [7] while the induction of the protein was
confirmed by Western blotting experiments (Fig. 11). The Aroclor
1254 treated cultures were subjected to genome-wide transcript
profiling. Using stringent criteria, 536 unique RefSeq-annotated
genes were defined as differentially expressed (Supplementary
Table S10). Of these, 383 genes were up-regulated and 153
down regulated. The promoter sequences of regulated genes were
Figure 5. Promoter-proximal ES of HNF4a. a) Bootstrapping analysis of HNF4a binding motif (matrix M01031) in promoter-proximal and
promoter distal regions. 100 promoter-proximal ES (2138 to 22 relative to the TSS) were compared to 100 promoter-distal ES (224972 to 223489
relative to the TSS) by the bootstrapping analysis tool POBO [48]. Promoter-proximal ES show a significantly lower number of HNF4a motifs. b) ES
(300 bp surround the peak position) were sorted by their P-value (as calculated by the MAT algorithm) and divided into bins of 1,000 ES. For each bin
the number of HNF4a motif occurrences and the percentage of promoter-proximal ES were calculated. As can be seen, ES with a high P-value (weak
ES) are more likely to be located promoter-proximal but to contain no HNF4a binding motif.
doi:10.1371/journal.pone.0021667.g005
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newly identified ChIP-chip gene targets. An overlap of 63% or 336
differentially expressed genes (Supplementary Table S11) were
identified as HNF4a gene targets, therefore confirming the func-
tional importance of the ES identified in the ChIP-chip assay.
Finally, published data on HNF4a overexpressing mammalian
cell lines was compared with data of the present study. The over-
lap ranged from 65 to 94% of the genes identified (Supplemen-
tary Table S10). Importantly, the highest overlap was obtained
in studies that employed knock-down siRNA experiments to
validate their findings [32]. Therefore, gene targets reported here
might be considered more reliable.
Discussion
In the past, research on trans-acting factors and their cor-
responding cis-elements focused on promoter-proximal binding
sites. With the development of ChIP-chip assays, genome-wide
scans for transcription factor binding sites became feasible. This
improved considerably an understanding of basic mechanisms of
Figure 6. Cluster of HNF4a binding sites. a) The distribution of HNF4a binding sites (purple line chart, upper half) is compared to the distribution
of known genes on chromosome 10. Green arrows mark two gene-sparse regions in which ES are found. The red arrows mark two regions with a high
number of HNF4a binding sites and a low number of genes. Analyses were performed using the Ensembl tool Karyoview (http://www.ensembl.org/
Homo_sapiens/karyoview). b) Clusters of HNF4a binding sites in a genomic region on chromosome 10 with high content of binding sites (the region
marked by the second red arrow in a)). The binding sites identified in this study, displayed as blue peaks in the upper half, are presented using the
IGB genome browser. The binding sites are distributed in two clusters around the transcription start site of the ACSL5 locus and in the 39-region of
the VTI1A locus.
doi:10.1371/journal.pone.0021667.g006
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binding sites facilitating RNA processing events.
In the present study, a genome-wide map of HNF4a binding
sites was constructed. This protein plays an essential role in liver
development, and its master regulatory role in the maintenance of
the metabolic competence of the liver has stimulated research on
HNF4a targeted cancer therapies for its ability to revert liver
cancer to a less aggressive phenotype [35].
The present study evidences .90% of the HNF4a binding sites
to be located in promoter-distal regions and this distribution of ES
is similar to that reported for the ERa [13]. Notably, with the
exception of regions closer than 600 base pairs to the TSS, binding
sites were more frequently downstream. Therefore, ChIP-chip
assays focusing on promoter regions only [4,36] might miss the
majority of binding sites.
Moreover, an analysis of HNF4a motifs within ChIP-enriched
regions demonstrates as high accuracy as in identification of
HNF4a binding sites as achieved by the use of high resolution
tiling array.
Importantly, an unexpected high number of HNF4a binding
sites were identified. Even with stringent criteria, i.e. reproducible
identification of enriched regions by three different algorithms,
Figure 7. Chromosomal distribution of HNF4a ChIP enrichment sites. Each chromosome was divided into 150 ‘bins’, and within each bin the
number of ES was counted. In the blue line chart, the number of HNF4a binding sites within each bin is represented as a single data point. Below
each chromosome the minimum and maximum number of binding sites located in a single bin is given. Analyses were performed using the Ensembl
tool Karyoview (http://www.ensembl.org/Homo_sapiens/karyoview).
doi:10.1371/journal.pone.0021667.g007
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overrepresented motifs by use of the CEAS tool [43]. Shown are the 10 motifs with the most significant enrichment, while redundant motifs (i.e.
multiple motifs for the same transcription factor) were removed. The similarity or dissimilarity of the motifs is visualized by using Weblogo depiction
(http://weblogo.berkeley.edu/). Motif enrichment analysis with Genomatix RegionMiner and MATCH [11] are found in Supplementary Tables S3,
S4, S5.
doi:10.1371/journal.pone.0021667.g008
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repetitive elements, .17,500 binding sites could be mapped.
Moreover, the distribution of identified ES across the chro-
mosomes varied considerably and the chromosomal distribution of
ES was not randomly distributed; rather clusters were identi-
fied (Fig. 6a, Fig. 7). Evidence was also obtained for the Y
chromosome to be devoid of HNF4a ES (Supplementary
Table S6). Note, of the 41 known and 14 novel protein coding
genes on the Y chromosome (http://www.ensembl.org/index.
html) several function in testis development and gender determi-
nation and include the SRY and TSPY proteins. While no vital
genes are located on the Y chromosome several diseases can be
linked to defective Y chromosome. It is tempting to speculate that
the significant overlap between the ERa and the HNF4a motif
and the functional interaction of these transcription factors
possible determined, at least in part, evolution and thus gene
selection of the Y chromosome.
Note, enhancer elements are constituted by clusters of binding
sites for different transcription factors [37]. The increased
conservation of the detected HNF4a binding sites, together with
the highly significant enrichment of binding motifs of several other
transcription factors in close vicinity, is suggestive for the identified
binding sites to be functionally important and to possibly form an
enhanceosome. Several sequence motifs were thus identified to be
significantly overrepresented in ES regions of HNF4a while
CART was significantly underrepresented as compared to the
genomic background.
Based on a thorough and detailed motif analysis, a close
relationship between HNF4a and AP1, GATA, ERa or HNF1a
binding could be established. While single cases of synergistic
action of HNF4a with HNF1a [38], ERa [39] or GATA
Figure 9. Distribution of AP1, CART, ERa, GATA2, HNF1a and SREBP motifs within regions enriched by HNF4a-ChIP. a) Peak positions
(represented as 0) were extended to 500 bp in both directions, and Motifs were detected by use of the MATCH algorithm [11] using cutoff criteria to
minimize the sum of false positives and false negatives. Regions were segmented into bins of 25 bp, and the number of occurrences of the different
motifs within each bin was counted. b) Plot of the relative distance of HNF4a motifs to other motifs enriched in the ChIP region. Within ChIP regions
the most conserved HNF4a motifs where identified. The sequences of the 500 nucleotides surrounding these most conserved HNF4a motifs where
retrieved and analyzed for those motifs of other TF that were also enriched in the ChIP regions. Then, the distance between these motifs and the
HNF4a motif was calculated using CisGenome for motif detection and plotted as histogram using bins of 20 bp. The HNF4a motif is found at the
center, reaching from bp 26t ob p+6. HNF4a and ERa share common and overlapping binding sites. c) Display of the overlap between the
binding motifs of HNF4a and the estrogen receptor (ERa) by use of Weblogo illustrations. Both motifs show a partial overlap. d) Overlap between ERa
binding sites and HNF4a binding sites. The high stringency set of ERa binding sites identified by ChIP-chip [13] was obtained. The percentage of ERa
binding sites identified in this study and also bound by HNF4a is displayed in a bar chart. The overlap of ERa binding sites with random control
regions was determined.
doi:10.1371/journal.pone.0021667.g009
Figure 11. HNF4a protein expression and DNA binding activity
with nuclear extracts isolated from Aroclor 1254 treated Caco-
2 cells. a) HNF4a Western blotting of 20 mg Caco-2 cell extract. A clear
induction of HNF4a protein expression was seen after 48 h and 72 h of
Aroclor1254 treatment. b) Electrophoretic mobility shift assays with
2.5 mg Caco-2 cell nuclear extract and oligonucleotides corresponding
to the A-site of the HNF1a promoter (HNF1pro) as 32P labeled probe. In
supershift assays an antibody directed against HNF4a (+) was added.
Binding of HNF4a was significantly increased after 72 h of Aroclor1254
induction.
doi:10.1371/journal.pone.0021667.g011
Figure 10. Comparison of HNF4a binding sites amongst
different published studies. Percentage of HNF4a binding sites
identified by Rada-Iglesias et al. [3] or Odom et al. [4] which could be
confirmed in this study. For Rada-Iglesias et al. a control group of
random genomic sequences was used to calculate the random overlap.
For Odom et al., a control group was created by selecting randomly a
number of promoter regions from the Huk13 array used in their study,
equal to the number of promoters they detected as being bound by
HNF4a.
doi:10.1371/journal.pone.0021667.g010
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importance is now demonstrated. To the best of our knowledge a
cooperation of HNF4a with AP1 at HNF4a enriched binding sites
has not been reported so far.
To further probe the functional importance of the newly
identified binding sites transcript expression of targeted genes at
varying HNF4a protein levels was studied. These studies con-
firmed 536 unique RefSeq-annotated genes to be differentially
expressed. The promoter sequences of regulated genes were
further analyzed and 63% or 336 differentially expressed genes
(Supplementary Table S11) were identified as HNF4a gene
targets, therefore confirming the functional importance of the ES
identified in the ChIP-chip assay. Hence, for some of the identified
genes the biological relevance could be established. Nonetheless,
further studies are in need to determine functional importance for
the many other ES sites, and this could possibly be achieved with
an additional control in ChIP-chip studies where the DNA binding
domain of HNF4a has been disabled.
Additionally, over 90% of the ES are promoter distal sequences
but could be defined as enhancer elements, while promoter
proximal sites were also identified and compared to random
controls. This suggests for HNF4a to interact directly and
indirectly with the basal transcriptional machinery. The actual
number of promoter-proximal binding sites will even be higher, as
the TSS of RefSeq annotated genes were examined only. In the
past, enhancers could hardly be identified by the available me-
thods; with the advent of genomic platform technologies the
comprehensive mapping of transcription factors is enabled to
define enhancer elements, as attempted within the ENCODE
regions [40].
Overall, HNF4a is truly a master regulatory protein in the
orchestration of a wide range of biological processes. Knowledge
on genes targeted by HNF4a will thus help to decipher the genetic
basis of fundamental biological processes and its aberrant regu-
lation in diseases [7,41,42].
In conclusion, a genome-wide map of HNF4a binding sites is
reported to better understand basic mechanisms of transcriptional
control of HNF4a targeted genes. Novel promoter distal binding
sites are identified in facilitating RNA processing events and a
gene repository is made available that is of utility in obtaining
fundamental knowledge on the basic genetic events in disease.
Materials and Methods
Caco-2 Cell Culture, Chromatin immunoprecipitation
(ChIP) and Aroclor 1254 treatment
Caco-2 cell culture, ChIP and chromatin preparation were
performed as previously described [41], with the exception that
the blocking steps with herring sperm DNA were omitted. High
specificity of the antibody against HNF4a (Santa Cruz sc 65566)
used for the IP was confirmed by Western blot analysis. After
ChIP, enrichment of two binding sites in the promoter regions of
HNF1a and AGT was confirmed by quantitative real time PCR
while Aroclor treatment was performed as described previously
[34].
ChIP-chip assay
Three samples displaying high enrichment for positive controls
were selected for ChIP-chip experiments. Total input DNA from
three independent biological replicates was diluted to the same
concentration as the corresponding ChIP-sample and amplified in
parallel with ChIP-samples from the three independent biological
replicates. Amplification was performed according to the Affyme-
trix protocol. The cycle number and amount of taq polymerase was
optimized for unbiased amplification. For fragmentation and
labeling of the amplified DNA, the GeneChIP WT Double-
Stranded DNA Terminal Labeling Kit from Affymetrix (P/N
900812) was used. Fragmentation success was confirmed with
he Agilent Bioanalyzer 2100. The labeled samples were hybridized
to Affymetrix Human tiling 2.0R arrays with a 35 base pair
resolution.
Raw data (CEL-files generated by GCOS after scanning) were
analyzed for enriched regions by three independent algorithms,
TAS [8], MAT [9] and Tilemap [10]. The following parameters
were chosen for ES identification: MAT bandwidth=200, maxi-
mum gap=300, minimum probes=8, P-value,0.00001 and
MAT score.5; Tilemap truncation=21000000, 1000000, trans-
form=none, GAP,=300/probes between peaks,=5, mini-
mum length 200 nt / 5 probes, region summary method=HMM
(a peak 28 probes on average, cutoff 0.5), FDR=left tail and
FDR,0.015; TAS bandwidth=400, P-value,0.01, minimum
run=200 and maximum gap=250. Resulting regions were
intersected usingthe Galaxy tool (http://g2.trac.bx.psu.edu/). After
intersection enriched regions shorter than 200 bp were removed.
ChIP and enrichment validation by real-time PCR
ChIP-DNA from three independent experiments was used for
further validation. Realtime PCR was performed on the Light
Cycler (Roche Diagnostics, Mannheim, Germany) with the
following conditions: denaturation at 94uC for 120 s, extension
at 72uC for different times and fluorescence at different tem-
peratures. Primer sequences, annealing times and temperatures,
extension times and fluorescence temperatures are summarized in
Supplementary Table S12. Dct-values were calculated versus
diluted total input, and calculation of DDct-values was performed
using a b-actin negative control.
Sequence conservation analysis
ES centers or peak positions detected by MAT were analyzed
with CEAS [43] for conservation and motif content (see Fig. 3).
For conservation analysis, CEAS extends genomic regions to
3,000 bp, and calculates for each nucleotide the average conserva-
tion score, based on the high-quality phast-Cons [44] information
from the UCSC Genome Browser (http://genome.ucsc.edu/).
The average conservation scores were plotted against the nucleo-
tides position.
Analysis of sequences for TF binding motifs
Sequence analysis for the detection of TF binding motifs was
done with MATCH [11] and CisGenome (http://www.biostat.
jhsph.edu/,hji/cisgenome/). Additionally, identification of en-
riched motifs within ChIP-chip detected regions was done with
CEAS [43] and the Genomatix RegionMiner (http://www.
genomatix.de/index.html).
Correlation of HNF4a binding sites to RefSeq annotated
genes and Gene Ontology categorization
The distribution of binding sites relative to TSS was analyzed,
and a list of all RefSeq genes and their TSS was obtained from
http://genome.ucsc.edu/. The closest TSS to each ES center was
calculated in the application Microsoft Excel.
Enrichment of binding sites in introns was determined in
RefSeq genes and their intron/exon structure was obtained from
http://genome.ucsc.edu/. The number of ChIP regions and of
regions from the random control set which overlap introns was
determined using the intersect function of the Galaxy tool (http://
g2.trac.bx.psu.edu/).
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annotated genes was performed with the software tool CisGenome
(http://www.biostat.jhsph.edu/,hji/cisgenome/). ES were deter-
mined for all RefSeq genes with transcript coding regions within
100,000 bp from the center of the ES. All RefSeq genes associated
with an ES were joined into a single list which was used for Gene
Ontology categorization. Gene Ontology categorization was done
with GOFFA [45].
Expression profiling
Total RNA was isolated with the QIAGEN’s RNeasy isolation
kit and 10 mg of total RNA was used for subsequent hybridization
experiments according to the manufacturer’s recommendations
and as described by Rohrbeck and Borlak [46]. Samples were
hybridized to the Affymetrix U133Plus2.0 genechip arrays. The
GCOS 1.4 software was used to calculate the level of differential
expressed genes. Cutoff criteria for up- and down regulated genes
were a logarithmized signal ratio .1.5, a present call and a signal
.100 after 48 and 72 hours.
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Table S3 Motif enrichment analysis with MATCH [11]. Match
analysis was performed with the ‘Vertebrate_all’ matrix set (578
matrices), with cutoff criteria set to minimize false positives.
Regions analyzed were the 300 basepairs surrounding the peak
positions. Motifs were counted and ratios between ChIP and
random control regions were calculated. P-value was calculated
based on a binomial distribution. To achieve stringent P-value
calculations, the number of trials was set to ‘‘(region length -
average motif length) * region number’’. Cutoffs for enriched or
depleted motifs were set to |Fold Change|.1,5 and P-value
,1*10
210. Motifs with less than 50 hits in the HNF4a ChIP
enriched regions and less than 25 hits in the random control
regions have been excluded. P-Values,0E-15 were set to zero by
Excel.
(DOC)
Table S4 Motif enrichment analysis with RegionMiner (Geno-
matix Software GmbH, Munich, Germany). Analysis of motif
enrichment for single transcription factor matrices was performed
with Genomatix RegionMiner. Cutoffs for enriched or depleted
motifs were set to |Fold Change|.1,3 and |Z-score|.20.
(DOC)
Table S5 Enrichment analysis for transcription factor matrices
families. Analysis of enrichment for transcription factor matrices
families was performed with Genomatix RegionMiner. Cutoffs for
enriched or depleted families were set to |Fold Change|.1,3 and
|Z-score|.20.
(DOC)
Table S6 HNFa binding site frequency varies between chro-
mosomes. The number of HNF4a binding sites on different
chromosomes was compared with the number of RefSeq anno-
tated genes and the length of the chromosomes. Chromosome
length and gene numbers were retrieved from (http://genome.
ucsc.edu/).
(DOC)
Table S7 HNF4a binding site clusters. HNF4a binding site
clusters were identified by scanning the genome for regions con-
taining 10 or more binding sites within a window of 100.000 bp.
Genes with a TSS located within or close to these clusters with a
high density of binding sites are given in the last column.
(DOC)
Table S8 Genes closest to novel HNF4alpha binding sites.
(XLS)
Table S9 Gene ontology terms of metabolism, development and
transport are overrepresented among HNF4a RefSeq target genes
identified in this study. Genes were analyzed with the Arraytrack
Software tool GOFFA [45] for overrepresented ontologies. The 102
most significant terms fulfilling the cutoff criteria (P value,0.005;
E value.1.2; hits $10) defining biological processes are given.
(DOC)
Table S10 Gene regulation upon Aroclor1254 treatment of
Caco-2 cells.
(XLS)
Table S11 Comparison of RefSeq-annotated HNF4a targets
identified by ChIP-chip to HNF4a targets identified by expression
profiling in this study and in different publications. In the second
column, the number of reported target genes from the relevant
study, which could be associated to a current RefSeq annotation,
is given. In the third column, the number of those RefSeq
annotation is given, which could be also associated with a target
gene identified in our ChIP-chip study. As 6670 from 18274
RefSeq Gene Symbols were identified as potential targets
by ChIP-chip, the expected overlap by chance was 6670/18274*
536=36%.
(DOC)
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